Immunovant

IMVT | NASDAQ | 0 Urmăritori

$18.13

+3.60%

$0.63

Urmărește

Overview Metrics Financials

Fair Price

$15.89

Overvalued by 94.0%

Pentru a afișa prețul corect al unei acțiuni, trebuie să fiți membru Bulios Black.

Profile

Immunovant, Inc. is an American biotechnology company focused on the development of innovative immunotherapies for the treatment of autoimmune diseases. The company specializes in the development of monoclonal antibodies that target specific immune pathways, which can help patients suffering from conditions such as myasthenia gravis, autoimmune hemolytic anemia, and others. Immunovant aims to provide effective therapeutic options for patients whose current treatments are insufficient or associated with undesirable side effects.

Feed

There are no posts to show right now.

Immunovant

Fair Price

Profile

Feed

Logare în Bulios

Creează-ți profilul pe Bulios

De ce Bulios?